Catalysts for $NVS

COSENTYX (SECUKINUMAB) — FDA approval

COSENTYX (SECUKINUMAB) — FDA approval

MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval

MEKINIST (TRAMETINIB) — FDA approval

TRILEPTAL (OXCARBAZEPINE) — FDA approval

TRILEPTAL (OXCARBAZEPINE) — FDA approval

COSENTYX (SECUKINUMAB) — FDA approval

COSENTYX (SECUKINUMAB) — FDA approval

SCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approval

TAFINLAR (DABRAFENIB MESYLATE) — FDA approval

MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval

TAFINLAR (DABRAFENIB MESYLATE) — FDA approval

MEKINIST (TRAMETINIB) — FDA approval

SCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approval

LEQVIO (INCLISIRAN SODIUM) — FDA approval

KESIMPTA (OFATUMUMAB) — FDA approval

COSENTYX (SECUKINUMAB) — FDA approval

TAFINLAR (DABRAFENIB MESYLATE) — FDA approval

MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval

TAFINLAR (DABRAFENIB MESYLATE) — FDA approval

MEKINIST (TRAMETINIB) — FDA approval

GLEEVEC (IMATINIB MESYLATE) — FDA approval

TAFINLAR (DABRAFENIB MESYLATE) — FDA approval

MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval

TAFINLAR (DABRAFENIB MESYLATE) — FDA approval

MEKINIST (TRAMETINIB) — FDA approval

KESIMPTA (OFATUMUMAB) — FDA approval

COSENTYX (SECUKINUMAB) — FDA approval

COSENTYX (SECUKINUMAB) — FDA approval

SCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approval